All Posts Tagged With: "VIVO"
(AAPL) 2011 Second Quarter Earnings Preview – Detailed
Earnings Preview 7/15/11
Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are...
(VIVO) FDA OKs Meridian C. Difficile Test
Diagnostic test kit maker Meridian Bioscience (VIVO) has clinched the approval of U.S. Food and Drug Administration (“FDA”) for its new C. difficile (Clostridium difficile) test dubbed Premier...
(VIVO) Meridian Bioscience Slashes Outlook For 2010
Life science company, Meridian Bioscience, Inc. (VIVO), recently slashed its outlook for fiscal 2010 (ending Sep 30, 2010) mainly due to a weaker-than-expected H1N1 season and lower C. difficile product revenues.
The...
(VIVO) Meridian Bioscience Misses Expectations by a Penny
Recently, Meridian Bioscience Inc. (VIVO) reported results for the first quarter of fiscal 2010. The company earned 22 cents per share in the quarter which fell short of the Zacks Consensus Estimate by a...
(AYI) Zacks #5 Rank Additions for Monday – Zacks Tale of the Tape
Here are the stocks added to the Zacks #5 Rank (“strong sell”) List today:
- Acuity Brands Inc (AYI)
- Anthracite...
8Jun2009 | vitalstocks | 0 comments | Continued